Gibb D, et al. Impact of raltegravir intensification of first-line art on IRIS in the REALITY trial. CROI 2018. Abstract 23.
Benralizumab, dupilumab of mepolizumab: lagere SARS-CoV-2-immuniteit na vaccinatie
okt 2024 | Astma, Eczeem, Vaccinatie, Virale infecties